Eli Lilly and Company vs Allstate Corporation
Side-by-side earnings signal comparison from SEC quarterly filings
Verdict
Eli Lilly and Company (LLY) carries a "Tailwind" signal with +73.1% revenue growth, while Allstate Corporation (ALL) is "Neutral" with +3.0% revenue growth. Both companies report in the Healthcare and Financials sectors.
| Metric | Eli Lilly and Company (LLY) | Allstate Corporation (ALL) |
|---|---|---|
| Operator Signal | Tailwind | Neutral |
| Signal Confidence | HIGH | HIGH |
| Latest Revenue | $19.8B | $16.9B |
| Revenue Growth | 73.1%* | 3.0% |
| Latest EPS | $8.26 | $9.25* |
| EPS Growth | 672.0%* | 338.4% |
| Sector | Healthcare | Financials |
| Quarters Tracked | 8 | 8 |
Eli Lilly and Company (LLY) carries a "Tailwind" signal with +73.1% revenue growth, while Allstate Corporation (ALL) is "Neutral" with +3.0% revenue growth. Both companies report in the Healthcare and Financials sectors.